The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal transplant recipients. (June 2016)

• Record Type: Journal Article
• Authors: Leberkühne, Lynn J.; Ebtehaj, Sanam; Dimova, Lidiya G.; Dikkers, Arne; Dullaart, Robin P.F.; Bakker, Stephan J.L.; Tietge, Uwe J.F.
• Is Part Of: Atherosclerosis. Volume 249(2016)
• Page Start: 181
• Page End: 185
• Publication Date: 2016-06
• Subjects: HDL -- HDL function -- Atherosclerosis -- Prospective study -- Kidney transplantation; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2016.04.008
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Background: Protection of low-density lipoproteins (LDL) against oxidative modification is a key anti-atherosclerotic property of high-density lipoproteins (HDL). This study evaluated the predictive value of the HDL antioxidative function for cardiovascular mortality, all-cause mortality and chronic graft failure in renal transplant recipients (RTR). Methods: The capacity of HDL to inhibit native LDL oxidation was determined in vitro in a prospective cohort of renal transplant recipients (RTR, n = 495, median follow-up 7.0 years). Results: The HDL antioxidative functionality was significantly higher in patients experiencing graft failure (57.4 ± 9.7%) than in those without (54.2 ± 11.3%; P = 0.039), while there were no differences for cardiovascular and all-cause mortality. Specifically glomerular filtration rate ( P = 0.001) and C-reactive protein levels ( P = 0.006) associated independently with antioxidative functionality in multivariate linear regression analyses. Cox regression analysis demonstrated a significant relationship between antioxidative functionality of HDL and graft failure in age-adjusted analyses, but significance was lost following adjustment for baseline kidney function and inflammatory load. No significant association was found between HDL antioxidative functionality and cardiovascular and all-cause mortality. Conclusion: This study demonstrates that the antioxidative function of HDL (i) does not predict cardiovascular or all-cause mortality in RTR, but (ii) conceivably contributes to the development of graft failure, however, not independent of baseline kidney function and inflammatory load. Highlights: HDL function represents an emerging concept in cardiovascular research. This prospective study focussed on the anti-oxidative function of HDL. HDL function was determined in 495 renal transplant recipients. Kidney function and inflammatory state associated independently with HDL function. HDL function did not independently predict mortality or graft failure.